Skip to main content
. 2004 Oct;42(10):4419–4431. doi: 10.1128/JCM.42.10.4419-4431.2004

TABLE 3.

In vitro susceptibilities of opportunistic non-Candida yeast-like fungi to new and established antifungal agents determined by NCCLS M27-A2 broth dilution MIC methodsa

Species Antifungal agent No. of isolates tested MIC (μg/ml)
Reference
Range 50% 90%
T. asahii Amphotericin B 43 1-8 4 4 2
Fluconazole 43 0.25-16 2 8 2
Itraconazole 43 0.06-4 0.5 1 2
Ravuconazole 24 0.25->16 0.5 NAb 75
Posaconazole 24 0.06->16 0.12 NA 75
Voriconazole 24 0.03->16 0.25 NA 75
Non-T. asahii Amphotericin B 15 0.06-1 0.25 NA 75
Fluconazole 15 0.5-4 2 NA 75
Itraconazole 15 0.03-0.5 0.12 NA 75
Ravuconazole 15 0.03->16 0.5 NA 75
Posaconazole 15 0.03-0.5 0.12 NA 75
Voriconazole 15 0.03-0.25 0.06 NA 75
T. beigelii Amphotericin B 5 0.5-2 2 NDc 25
Fluconazole 5 1-2 2 ND 25
Itraconazole 5 0.06-0.25 0.25 ND 25
Posaconazole 5 0.12-1 1 ND 24
Voriconazole 5 <0.03-0.12 <0.03 ND 25
Caspofungin 5 16->16 >16 ND 24
Anidulafungin 5 >16 >16 ND 24
Rhodotorula spp. Amphotericin B 35 0.12-0.5 0.25 0.5 28
Flucytosine 35 0.06-0.25 0.12 0.25 28
Fluconazole 35 32-256 256 256 28
Itraconazole 35 0.25-1 1 1 28
Posaconazole 54 0.25->8 2 4 21
Ravuconazole 56 0.015-2 0.25 1 21
Voriconazole 55 0.25->8 2 4 21
Caspofungin 55 8->8 >8 >8 21
Micafungin 10 >64 >64 >64 113
Geotrichum capitatum Amphotericin B 23 0.06-0.25 0.12 0.12 30
Flucytosine 23 0.12-16 0.12 4 30
Fluconazole 23 1-32 8 8 30
Itraconazole 23 0.03-0.5 0.12 0.25 30
Voriconazole 23 0.03-0.5 0.25 0.25 30
Anidulafungin 4 1-4 4 ND 6
a

Testing was performed as described in reference 67.

b

NA, not available.

c

ND, not done.